drugset / Trial / NCT00515281

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

NCT00515281 ↗

Phase 2/3 Terminated 273 enrolled University of Chicago
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.

Timeline

Start
2008-05
Primary completion
2023-06-07
Completion
2023-11-28

Outcome

Outcome not reported

Stopped (Enrollment): “The pace of patient enrolledment forced recruitment to stop after 273 patients.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Inhaled Nitric Oxide Unknown — Inhaled
Background Oxygen Other / unclassified — —